Anti-Epidermal Growth Factor Receptor Therapy in <i>EGFR</i>-Amplified Esophagogastric Cancers: An Underestimated Efficacy.
- DOI
- 10.1200/po-25-00209
- Published
- 2025-12-10
- Container
- JCO Precis Oncol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/po-25-00209,
title = {Anti-Epidermal Growth Factor Receptor Therapy in \<i\>EGFR\</i\>-Amplified Esophagogastric Cancers: An Underestimated Efficacy.},
author = {Valéry M and Vasseur D and Megherbi A and Boilève A and Tarabay A and Pudlarz T and Fuerea A and Camilleri G and Diebakate L and Benhaim L and Barbe R and Boige V and Ducreux M and Bani M and Smolenschi C and Hollebecque A.},
year = {2025},
journal = {JCO Precis Oncol},
doi = {10.1200/po-25-00209},
url = {https://doi.org/10.1200/po-25-00209}
}RIS
TY - JOUR TI - Anti-Epidermal Growth Factor Receptor Therapy in <i>EGFR</i>-Amplified Esophagogastric Cancers: An Underestimated Efficacy. AU - Valéry M AU - Vasseur D AU - Megherbi A AU - Boilève A AU - Tarabay A AU - Pudlarz T AU - Fuerea A AU - Camilleri G AU - Diebakate L AU - Benhaim L AU - Barbe R AU - Boige V AU - Ducreux M AU - Bani M AU - Smolenschi C AU - Hollebecque A. PY - 2025 JO - JCO Precis Oncol DO - 10.1200/po-25-00209 UR - https://doi.org/10.1200/po-25-00209 ER -
APA
M, V., D, V., A, M., A, B., A, T., T, P., A, F., G, C., L, D., L, B., R, B., V, B., M, D., M, B., C, S., & A., H. (2025). Anti-Epidermal Growth Factor Receptor Therapy in <i>EGFR</i>-Amplified Esophagogastric Cancers: An Underestimated Efficacy.. JCO Precis Oncol. https://doi.org/10.1200/po-25-00209
Source records
- europe-pmc · retrieved 2026-09-26T18:02:16.206Z